Yusuke Harada

Thiolactomycin, a new antibiotic. IV. Biological properties and chemotherapeutic activity in mice.

Satohide Miyakawa, Koji Suzuki, TAKAO NOTO et al. · The Journal of Antibiotics · 1982 · 116 citations · Full text

Adipose Tissue-Derived Regenerative Cells Improve Implantation of Fertilized Eggs in Thin Endometrium

Fusanori Yotsumoto, Hideki Iwaguro, Yusuke Harada et al. · Regenerative Medicine · 2020 · 45 citations

Nimesulide, a cyclooxygenase-2 selective inhibitor, suppresses obesity-related non-alcoholic fatty liver disease and hepatic insulin resistance through the regulation of peroxisome proliferator-activated receptor γ

Shunsuke Tsujimoto, Manabu Kishina, Masahiko Koda et al. · International Journal of Molecular Medicine · 2016 · 41 citations · Full text

Cox-2 Selective Inhibitor, Fatty Liver Disease, Insulin Signaling +18

Estimated incidence per population of adverse drug reactions to Kampo medicines from the Japanese adverse drug event report database (JADER)

Ichiro Arai, Yusuke Harada, Hiroshi Koda et al. · Traditional & Kampo Medicine · 2019 · 19 citations

Kampo Formulation, Pharmacotherapy, Adverse Drug Reaction +18

Early adrenal infection by herpes simplex virus type-1 (Miyama + GC strain): special reference to inoculation dose and spread from the adrenal to the central nervous system

Hiroshi Irie, Yusuke Harada, Eri Kurokawa et al. · Virchows Archiv B Cell Pathology Including Molecular Pathology · 1987 · 14 citations